Related Experiment Videos

The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population

Xin Tu1, Shaofang Nie, Yuhua Liao

  • 1Key Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and Technology, Center for Human Genome Research, Cardio-X Institute, Huazhong University of Science and Technology, Wuhan 430074, China.

American Journal of Human Genetics
|October 1, 2013
PubMed

Insights

Genetic variations in the interleukin-33 (IL-33) and ST2L pathway are strongly linked to coronary artery disease (CAD). This pathway appears to play a causal role in CAD development, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Cardiovascular Genetics
  • Molecular Biology

Background:

  • Interleukin-33 (IL-33) is a key immune mediator, but its role in cardiovascular diseases, particularly coronary artery disease (CAD), remains unclear.
  • The ST2L receptor, which binds IL-33, is implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the genetic association of the IL-33-ST2L pathway with coronary artery disease (CAD).
  • To determine if specific genetic variants in IL33 and IL1RL1 influence CAD risk and IL-33 expression.

Main Methods:

  • Three-stage case-control association study involving 4,521 CAD patients and 4,809 controls.
  • Analysis of tag single nucleotide polymorphisms (SNPs) in IL33 and IL1RL1 genes.
  • Reporter gene assays to assess the impact of SNPs on gene expression.
  • Correlation analysis between genotype and plasma IL-33 levels.

Main Results:

  • Significant associations found between specific SNPs (rs7025417 in IL33, rs11685424 in IL1RL1) and CAD risk.
  • Combined variants increased CAD risk nearly 5-fold.
  • SNPs rs7025417 and rs11685424 altered IL33 and IL1RL1 gene expression.
  • Genotype rs7025417 was significantly associated with higher plasma IL-33 levels.

Conclusions:

  • Genetic evidence suggests the IL-33-ST2L pathway has a causal role in the development of CAD.
  • This pathway represents a promising target for CAD prevention and treatment strategies.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...